A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Latest Information Update: 29 Jun 2023
At a glance
- Drugs Bambuterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 25 Feb 2013 New trial record